Shanghai Pharma, Vitaco deal needs New Zealand investment office clearance
The takeover of Australia-listed vitamin producer Vitaco by Shanghai Pharmaceuticals and its private equity partner, Primavera Capital, needs clearance from New Zealand’s Overseas Investment Office.The takeover of Australia-listed vitamin producer Vitaco...To view the full article, register now.
Already a subscriber? Click here to view full article